Kevin Lobo's 8+ years as Stryker CEO: Leading 20+ acquisitions, boosting robotics & more

Alan Condon -   Print  |

In 2012, 18 months after Kevin Lobo joined Stryker as group president of orthopedics, the company appointed him as CEO.

Here are 10 things to know about Mr. Lobo:

1. Mr. Lobo, 54, has more than 24 years of experience, holding several executive positions in general management and finance. Before entering the medical device industry, he worked for KPMG, Unilever and Kraft Canada.

2. His net worth is estimated at $48.6 million, according to Wallmine. Mr. Lobo owns more than $5.75 million of Stryker stock and makes a $13.9 million salary.

3. Prior to Stryker, Mr. Lobo spent eight years at Johnson & Johnson, where he served as president of Johnson & Johnson Medical Canada and president of Ethicon Endo Surgery. While at Johnson & Johnson, he also operated as CFO of McNeil Consumer Healthcare and Ortho Women's Health and Urology.

4. During his tenure as Stryker CEO, he spearheaded more than 20 acquisitions, including Mako Surgical, K2M, Trauson Holdings and Mobius Imaging.

5. Trauson Holdings, China's largest manufacturer of pelvic reconstruction plates, was the first acquisition Mr. Lobo led. Stryker acquired the company in a $764 million all-cash transaction in 2013. 

6. Stryker splashed $1.65 billion to acquire Mako Surgical that same year. Four years later, the company launched the robotic-arm assisted total knee replacement application for use with the Mako System.

7. Additionally, Mr. Lobo serves as a board member for Parker Hannifin Corp., Advanced Medical Technology Association, Business Leaders for Michigan and United Way.

8. Mr. Lobo was born in Mumbai, India, before his family moved to Canada, where he grew up. He is fluent in English, French and speaks some Konkani and Hindi.

9. He graduated with a bachelor's degree in commerce from McGill University in Montreal, Canada, and a master's in business from the University of Toronto.

10. Mr. Lobo's goals for this year are to accelerate Stryker's spine program and focus on spinal robotics after the $500 million acquisition of Mobius and its subsidiary Cardan Robotics in October 2019.

More articles on devices:
Aetna illegally refused to pay $75,200 for emergency spine procedure, practice alleges
Former Cleveland Clinic orthopedic surgeon joins Sintx Technologies' board of directors
Stryker appoints former DePuy, Johnson & Johnson executive as VP of investor relations

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers